Noninvasive assessment of characteristics of novel anti-HER2

A) Distribution of the log‐transformed serum anti‐HER2 autoantibody

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence - ScienceDirect

Full article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells

Ongoing trials using anti-HER2 agents in gastrointestinal tumors.

Cancers, Free Full-Text

Combination Therapies for Advanced Biliary Tract Cancer

Binding assay of the purified anti-HER2 scFv expressed from BL21 (DE3)

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Frontiers Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

IJMS, Free Full-Text